249 related articles for article (PubMed ID: 15693606)
1. Chemokines in the ischemic myocardium: from inflammation to fibrosis.
Frangogiannis NG
Inflamm Res; 2004 Nov; 53(11):585-95. PubMed ID: 15693606
[TBL] [Abstract][Full Text] [Related]
2. The role of the chemokines in myocardial ischemia and reperfusion.
Frangogiannis NG
Curr Vasc Pharmacol; 2004 Apr; 2(2):163-74. PubMed ID: 15320517
[TBL] [Abstract][Full Text] [Related]
3. Chemokines in myocardial ischemia.
Frangogiannis NG; Entman ML
Trends Cardiovasc Med; 2005 Jul; 15(5):163-9. PubMed ID: 16165012
[TBL] [Abstract][Full Text] [Related]
4. MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy.
Xia Y; Frangogiannis NG
Inflamm Allergy Drug Targets; 2007 Jun; 6(2):101-7. PubMed ID: 17692033
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling.
Zymek P; Nah DY; Bujak M; Ren G; Koerting A; Leucker T; Huebener P; Taffet G; Entman M; Frangogiannis NG
Cardiovasc Res; 2007 May; 74(2):313-22. PubMed ID: 17188669
[TBL] [Abstract][Full Text] [Related]
6. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
[TBL] [Abstract][Full Text] [Related]
7. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling.
Bujak M; Ren G; Kweon HJ; Dobaczewski M; Reddy A; Taffet G; Wang XF; Frangogiannis NG
Circulation; 2007 Nov; 116(19):2127-38. PubMed ID: 17967775
[TBL] [Abstract][Full Text] [Related]
8. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts.
Frangogiannis NG; Ren G; Dewald O; Zymek P; Haudek S; Koerting A; Winkelmann K; Michael LH; Lawler J; Entman ML
Circulation; 2005 Jun; 111(22):2935-42. PubMed ID: 15927970
[TBL] [Abstract][Full Text] [Related]
9. CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts.
Dewald O; Zymek P; Winkelmann K; Koerting A; Ren G; Abou-Khamis T; Michael LH; Rollins BJ; Entman ML; Frangogiannis NG
Circ Res; 2005 Apr; 96(8):881-9. PubMed ID: 15774854
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory mechanisms in myocardial infarction.
Ren G; Dewald O; Frangogiannis NG
Curr Drug Targets Inflamm Allergy; 2003 Sep; 2(3):242-56. PubMed ID: 14561159
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of chemokine expression in the retinal vasculature in ischemia-reperfusion injury.
Jo N; Wu GS; Rao NA
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):4054-60. PubMed ID: 12939328
[TBL] [Abstract][Full Text] [Related]
12. The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction.
Cochain C; Auvynet C; Poupel L; Vilar J; Dumeau E; Richart A; Récalde A; Zouggari Y; Yin KY; Bruneval P; Renault G; Marchiol C; Bonnin P; Lévy B; Bonecchi R; Locati M; Combadière C; Silvestre JS
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2206-13. PubMed ID: 22796582
[TBL] [Abstract][Full Text] [Related]
13. Role of chemokines and formyl peptides in pneumococcal pneumonia-induced monocyte/macrophage recruitment.
Fillion I; Ouellet N; Simard M; Bergeron Y; Sato S; Bergeron MG
J Immunol; 2001 Jun; 166(12):7353-61. PubMed ID: 11390486
[TBL] [Abstract][Full Text] [Related]
14. The role of chemokines and their receptors in the rejection of pig islet tissue xenografts.
Solomon MF; Kuziel WA; Mann DA; Simeonovic CJ
Xenotransplantation; 2003 Mar; 10(2):164-77. PubMed ID: 12588649
[TBL] [Abstract][Full Text] [Related]
15. Targeting the chemokines in cardiac repair.
Cavalera M; Frangogiannis NG
Curr Pharm Des; 2014; 20(12):1971-9. PubMed ID: 23844733
[TBL] [Abstract][Full Text] [Related]
16. CXC chemokines Gro(alpha)/IL-8 and IP-10/MIG in Helicobacter pylori gastritis.
Eck M; Schmausser B; Scheller K; Toksoy A; Kraus M; Menzel T; Müller-Hermelink HK; Gillitzer R
Clin Exp Immunol; 2000 Nov; 122(2):192-9. PubMed ID: 11091274
[TBL] [Abstract][Full Text] [Related]
17. The inflammatory response in myocardial infarction.
Frangogiannis NG; Smith CW; Entman ML
Cardiovasc Res; 2002 Jan; 53(1):31-47. PubMed ID: 11744011
[TBL] [Abstract][Full Text] [Related]
18. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy.
Frangogiannis NG; Dewald O; Xia Y; Ren G; Haudek S; Leucker T; Kraemer D; Taffet G; Rollins BJ; Entman ML
Circulation; 2007 Feb; 115(5):584-92. PubMed ID: 17283277
[TBL] [Abstract][Full Text] [Related]
19. DITPA, a thyroid hormone analog, reduces infarct size and attenuates the inflammatory response following myocardial ischemia.
Abohashem-Aly AA; Meng X; Li J; Sadaria MR; Ao L; Wennergren J; Fullerton DA; Raeburn CD
J Surg Res; 2011 Dec; 171(2):379-85. PubMed ID: 21658725
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling.
Bujak M; Dobaczewski M; Chatila K; Mendoza LH; Li N; Reddy A; Frangogiannis NG
Am J Pathol; 2008 Jul; 173(1):57-67. PubMed ID: 18535174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]